- Home
- WIW vs DNA Comparison
WIW vs DNA Comparison
Compare WIW & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIW
- DNA
- Stock Information
- Founded
- WIW 2004
- DNA 2008
- Country
- WIW United States
- DNA United States
- Employees
- WIW N/A
- DNA N/A
- Industry
- WIW Finance Companies
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WIW Finance
- DNA Health Care
- Exchange
- WIW Nasdaq
- DNA Nasdaq
- Market Cap
- WIW 536.0M
- DNA 658.5M
- IPO Year
- WIW N/A
- DNA N/A
- Fundamental
- Price
- WIW $8.83
- DNA $9.94
- Analyst Decision
- WIW
- DNA Sell
- Analyst Count
- WIW 0
- DNA 3
- Target Price
- WIW N/A
- DNA $9.67
- AVG Volume (30 Days)
- WIW 229.9K
- DNA 1.6M
- Earning Date
- WIW 01-01-0001
- DNA 08-07-2025
- Dividend Yield
- WIW 11.14%
- DNA N/A
- EPS Growth
- WIW N/A
- DNA N/A
- EPS
- WIW N/A
- DNA N/A
- Revenue
- WIW N/A
- DNA $237,417,000.00
- Revenue This Year
- WIW N/A
- DNA N/A
- Revenue Next Year
- WIW N/A
- DNA $15.91
- P/E Ratio
- WIW N/A
- DNA N/A
- Revenue Growth
- WIW N/A
- DNA 13.76
- 52 Week Low
- WIW $8.01
- DNA $5.00
- 52 Week High
- WIW $9.37
- DNA $16.85
- Technical
- Relative Strength Index (RSI)
- WIW 67.04
- DNA 50.93
- Support Level
- WIW $8.76
- DNA $8.21
- Resistance Level
- WIW $8.80
- DNA $13.33
- Average True Range (ATR)
- WIW 0.05
- DNA 0.90
- MACD
- WIW 0.00
- DNA -0.14
- Stochastic Oscillator
- WIW 100.00
- DNA 28.22
About WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.